Publications by authors named "Mayumi Tamura"

Galectins are β-galactoside-binding animal lectins involved in various biological functions, such as host defense. Galectin-2 and -3 are members of the galectin family that are expressed in the stomach, including the gastric mucosa and surface mucous cells. Galectin-3 exhibits aggregation and bactericidal activity against in a β-galactoside-dependent manner.

View Article and Find Full Text PDF

Due to a significant proportion of glycans binding to the peptide (constituting approximately 50-90% of the molecular weight), analyzing the interaction between the entire mucin molecule and its recognition protein (lectin) can be challenging. To address this, we propose a semiquantitative approach for measuring the interaction between mucin and lectin, which involves immobilizing mucin in a 96-well plate and subsequently adding lectin tagged with green fluorescent protein.

View Article and Find Full Text PDF

It is a challenging task to quantify mucin using conventional protein quantification methods due to the large number of glycans attached to the peptide, which make up approximately 50-90% of its molecular weight. To address this issue, we propose a simple quantification method that involves spotting mucins onto a membrane and staining them with Alcian blue.

View Article and Find Full Text PDF

Galectin-1 (Gal-1) is an evolutionarily conserved sugar-binding protein found in intra- and extracellular spaces. Extracellularly, it binds to glycoconjugates with β-galactoside(s) and functions in various biological phenomena, including immunity, cancer, and differentiation. Under extracellular oxidative conditions, Gal-1 undergoes oxidative inactivation, losing its sugar-binding ability, although it exhibits sugar-independent functions.

View Article and Find Full Text PDF

Galectin-2 (Gal-2) is an animal lectin with specificity for β-galactosides. It is predominantly expressed and suggested to play a protective function in the gastrointestinal tract; therefore, it can be used as a protein drug. Recombinant proteins have been expressed using Escherichia coli and used to study the function of Gal-2.

View Article and Find Full Text PDF

Osteoclasts are the only bone-resorbing cells in organisms and understanding their differentiation mechanism is crucial for the treatment of osteoporosis. In the present study, we investigated the effect of Thiamet G, an O-GlcNAcase specific inhibitor, on osteoclastogenic differentiation. Thiamet G treatment increased global O-GlcNAcylation in murine RAW264 cells and suppressed receptor activator of nuclear factor-κB ligand (RANKL)-dependent formation in tartrate-resistant acid phosphatase (TRAP)-positive multinuclear cells, thereby suppressing the upregulation of osteoclast specific genes.

View Article and Find Full Text PDF

S-nitrosylation, which involves the coupling of an NO group to the reactive thiol of Cys residue(s) in a polypeptide, is an important posttranslational modification detected in a variety of proteins. Here, we present the S-nitrosylation of recombinant galectin-2 (Gal-2) using S-nitrosocysteine and the measurement of the molecular ratio of S-nitrosylation of Cys residues in the Gal-2 protein.

View Article and Find Full Text PDF

is associated with the onset of gastritis, peptic ulcers, and gastric cancer. Galectins are a family of β-galactoside-binding proteins involved in diverse biological phenomena. Galectin-2 (Gal-2), a member of the galectin family, is predominantly expressed in the gastrointestinal tract.

View Article and Find Full Text PDF

Galectins are a group of animal lectins characterized by their specificity for β-galactosides. Of these, galectin-2 (Gal-2) is predominantly expressed in the gastrointestinal tract. In the current study, we used a mouse gastric mucous fraction to investigate whether Gal-2 is secreted from epithelial cells and identify its potential ligands in gastric mucus.

View Article and Find Full Text PDF

Galactoseβ1-4Fucose (GalFuc) is a unique disaccharide found in invertebrates including nematodes. A fungal galectin CGL2 suppresses nematode development by recognizing the galactoseβ1-4fucose epitope. The Caenorhabditis elegans galectin LEC-6 recognizes it as an endogenous ligand and the Glu67 residue of LEC-6 is responsible for this interaction.

View Article and Find Full Text PDF

Unlabelled: Galectin-2 (Gal-2) is a lectin thought to play protective roles in the gastrointestinal tract. Oxidation of mouse Gal-2 (mGal-2) by hydrogen peroxide (H O ) results in the loss of sugar-binding activity, whereas S-nitrosylation of mGal-2, which does not change its sugar-binding profile, has been shown to protect the protein from H O -induced inactivation. One of the two cysteine residues, C57, has been identified as being responsible for controlling H O -induced inactivation; however, the underlying molecular mechanism has not been elucidated.

View Article and Find Full Text PDF

Galectins comprise a group of animal lectins characterized by their specificity for β-galactosides. Galectin-2 (Gal-2) is predominantly expressed in the gastrointestinal tract and has been identified as one of the main gastric mucosal proteins that are proposed to have a protective role in the stomach. As Gal-2 is known to form homodimers in solution, this may result in crosslinking of macromolecules with the sugar structures recognized by Gal-2.

View Article and Find Full Text PDF
Article Synopsis
  • Osteoclasts are the only cells in the body that break down bone, and this study looked at how glucosamine (GlcN) affects their development in a specific type of mouse cell.
  • The researchers found that GlcN not only reduced the expression of important osteoclast genes more effectively than N-acetylglucosamine (GlcNAc), but it also hindered the activity and formation of these bone-resorbing cells.
  • The study concluded that GlcN likely suppresses osteoclastogenesis through changes in glycosylation patterns of proteins, notably increasing O-GlcNAcylation and decreasing specific sialic acid modifications.
View Article and Find Full Text PDF

Galectins are a group of animal lectins characterized by their specificity for β-galactosides. Mouse galectin-2 (mGal-2) is predominantly expressed in the gastrointestinal tract and has been identified as one of the main gastric mucosal proteins that are uniquely sensitive to S-nitrosylation. We have previously reported that oxidation of mGal-2 by hydrogen peroxide (HO) resulted in the loss of sugar-binding ability, whereas pre-treatment of mGal-2 with S-nitrosocysteine prevented HO-induced inactivation.

View Article and Find Full Text PDF

Osteoclasts are the only cells in an organism capable of resorbing bone. These cells differentiate from monocyte/macrophage lineage cells upon stimulation by receptor activator of NF-κB ligand (RANKL). On the other hand, osteoclastogenesis is reportedly suppressed by glucose via the downregulation of NF-κB activity through suppression of reactive oxygen species generation.

View Article and Find Full Text PDF

Galactoseβ1-4fucose (Galβ1-4Fuc) is a unique disaccharide unit that has been found only in the N-glycans of protostomia. We demonstrated that this unit has a role as an endogenous ligand for Caenorhabditis elegans galectins. This unit is also recognized by fungal and mammalian galectins possibly as a non-self glycomarker.

View Article and Find Full Text PDF
Article Synopsis
  • - Galectins are a group of proteins that bind to specific sugar molecules (β-galactoside sugars) due to their unique amino acid structure, and are used to understand how these interactions work outside of cells.
  • - Purifying galectins can be straightforward but becomes challenging with mutated versions that have lower sugar binding affinity; however, the galectin LEC-6 from the worm C. elegans maintains strong binding even when mutated.
  • - In research, various mutant forms of mouse galectin-1 were created to test their sugar binding ability; most mutants had low affinity for one sugar but could still be purified using another specific sugar (Galβ1-4Fuc), suggesting this could be a useful
View Article and Find Full Text PDF

Interferon-stimulated gene 15 kDa (ISG15) is a protein upregulated by interferon-β that negatively regulates osteoclastogenesis. We investigated the role of ISG15 in receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclastogenic differentiation of murine RAW264 cells. RANKL stimulation induced ISG15 expression in RAW264 cells at both the mRNA and protein levels.

View Article and Find Full Text PDF

Galectins are a group of animal lectins characterized by their specificity for β-galactosides. Galectin-2 (Gal-2) is predominantly expressed in the gastrointestinal tract. A proteomic analysis identified Gal-2 as a protein that was S-nitrosylated when mouse gastric mucosal lysates were reacted with S-nitrosoglutathione, a physiologically relevant S-nitrosylating agent.

View Article and Find Full Text PDF

Galectins are a group of animal lectins characterized by their specificity for β-galactosides. In our previous study, we showed that a human galectin-1 (hGal-1) mutant, in which a cysteine residue was introduced at Lys(28), forms a covalently cross-linked complex with the model glycoprotein ligands asialofetuin and laminin by using the photoactivatable sulfhydryl reagent benzophenone-4-maleimide (BPM). In the present study, we used several hGal-1 mutants in which single cysteine residues were introduced at different positions and examined their ability to form a covalent complex with asialofetuin or laminin by using BPM.

View Article and Find Full Text PDF

Galactoseβ1-4Fucose (Galβ1-4Fuc) is a unique disaccharide exclusively found in N-glycans of protostomia, and is recognized by some galectins of Caenorhabditis elegans and Coprinopsis cinerea. In the present study, we investigated whether mammalian galectins also bind such a disaccharide. We examined sugar-binding ability of human galectin-1 (hGal-1) and found that hGal-1 preferentially binds Galβ1-4Fuc compared to Galβ1-4GlcNAc, which is its endogenous recognition unit.

View Article and Find Full Text PDF

Galectins are a group of lectins that can bind carbohydrate chains containing β-galactoside units. LEC-6, a member of galectins of Caenorhabditis elegans, binds fucose-containing saccharides. We solved the crystal structure of LEC-6 in complex with galactose-β1,4-fucose (Galβ1-4Fuc) at 1.

View Article and Find Full Text PDF

Galβ1-4Fuc is a key structural motif in Caenorhabditis elegans glycans and is responsible for interaction with C. elegans galectins. In animals of the clade Protostomia, this unit seems to have important roles in glycan-protein interactions and corresponds to the Galβ1-4GlcNAc unit in vertebrates.

View Article and Find Full Text PDF
Article Synopsis
  • α(1)-Acid glycoprotein (AGP) serves as a potential marker for tracking disease progression and prognosis in cancer patients, analyzed through its various glycoforms using lectins.
  • A new technique using affinity capillary electrophoresis with fluorescein-labeled AGP and laser-induced fluorescence detection was developed for quantifying different lectin-reactive AGP forms.
  • This method allows for the efficient separation and quantification of AGP, making it a valuable tool for improving prognosis assessments in cancer patients.
View Article and Find Full Text PDF

Synopsis of recent research by authors named "Mayumi Tamura"

  • - Mayumi Tamura's research focuses on galectins, particularly Galectin-2, exploring their interactions with carbohydrates and biological functions, including their role in immunity, gastrointestinal health, and differentiation of osteoclasts.
  • - Notable findings include the characterization of the interaction between Galectin-2 and mucins, development of quantitative methods for mucin analysis, and the discovery that Galectin-1 can suppress osteoclast differentiation, which has implications for bone health and diseases like osteoporosis.
  • - Tamura's studies also highlight the protective roles of galectins against oxidative damage through post-translational modifications, shedding light on their potential therapeutic applications in treating gastrointestinal disorders and other conditions.